Thalidomide neuropathy: clinical, electrophysiological and neuroradiological features.

  title={Thalidomide neuropathy: clinical, electrophysiological and neuroradiological features.},
  author={Gianluca Isoardo and Mauro Bergui and Luca Durelli and Pierangelo Barbero and Mario Boccadoro and Alessandra Bertola and Palma Ciaramitaro and Andrea Palumbo and Bruno Bergamasco and Dario Cocito},
  journal={Acta neurologica Scandinavica},
  volume={109 3},
OBJECTIVE Thalidomide is a promising therapy for multiple myeloma. Sensory neuropathy is a side effect of thalidomide and resulted to be partially reversible in 50% of cases, suggesting a sensory ganglionopathy. Spinal cord magnetic resonance imaging (MRI) was found to be useful in the diagnosis of sensory ganglionopathies and we use it to determine if thalidomide neuropathy has features of a ganglionopathy. MATERIAL AND METHODS Six patients with multiple myeloma developed thalidomide-induced… CONTINUE READING